JP2022518456A5 - - Google Patents
Info
- Publication number
- JP2022518456A5 JP2022518456A5 JP2021541219A JP2021541219A JP2022518456A5 JP 2022518456 A5 JP2022518456 A5 JP 2022518456A5 JP 2021541219 A JP2021541219 A JP 2021541219A JP 2021541219 A JP2021541219 A JP 2021541219A JP 2022518456 A5 JP2022518456 A5 JP 2022518456A5
- Authority
- JP
- Japan
- Prior art keywords
- oxo
- group
- carboxylic acid
- tert
- butyl
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962793578P | 2019-01-17 | 2019-01-17 | |
| US62/793,578 | 2019-01-17 | ||
| PCT/US2020/013701 WO2020150366A1 (en) | 2019-01-17 | 2020-01-15 | Substituted polycyclic carboxylic acids, analogues thereof, and methods using same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022518456A JP2022518456A (ja) | 2022-03-15 |
| JP2022518456A5 true JP2022518456A5 (https=) | 2022-06-08 |
| JPWO2020150366A5 JPWO2020150366A5 (https=) | 2022-06-08 |
Family
ID=71613992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021541219A Pending JP2022518456A (ja) | 2019-01-17 | 2020-01-15 | 置換多環式カルボン酸、その類似体、およびそれらの使用法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20220125771A1 (https=) |
| EP (1) | EP3911653A4 (https=) |
| JP (1) | JP2022518456A (https=) |
| KR (1) | KR20210121044A (https=) |
| CN (1) | CN113825756A (https=) |
| AU (1) | AU2020208371A1 (https=) |
| BR (1) | BR112021014079A2 (https=) |
| CA (1) | CA3126102A1 (https=) |
| EA (1) | EA202191967A1 (https=) |
| IL (1) | IL284845A (https=) |
| MX (1) | MX2021008646A (https=) |
| PH (1) | PH12021551718A1 (https=) |
| SG (1) | SG11202106965RA (https=) |
| TW (1) | TW202033523A (https=) |
| WO (1) | WO2020150366A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10952978B2 (en) | 2017-08-28 | 2021-03-23 | Enanta Pharmaceuticals, Inc. | Hepatitis B antiviral agents |
| US11702427B2 (en) | 2018-03-12 | 2023-07-18 | Arbutus Biopharma Corporation | Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same |
| CN110862390B (zh) | 2018-08-28 | 2023-05-09 | 广东东阳光药业有限公司 | 稠合三环类化合物及其在药物中的应用 |
| UY38383A (es) | 2018-09-21 | 2020-04-30 | Enanta Pharm Inc | Heterociclos funcionalizados como agentes antivirales |
| CA3111046A1 (en) | 2018-09-30 | 2020-04-02 | Sunshine Lake Pharma Co., Ltd. | Fused tetracyclic compounds and uses thereof in medicine |
| US11198693B2 (en) | 2018-11-21 | 2021-12-14 | Enanta Pharmaceuticals, Inc. | Functionalized heterocycles as antiviral agents |
| US11738019B2 (en) | 2019-07-11 | 2023-08-29 | Enanta Pharmaceuticals, Inc. | Substituted heterocycles as antiviral agents |
| US11236108B2 (en) * | 2019-09-17 | 2022-02-01 | Enanta Pharmaceuticals, Inc. | Functionalized heterocycles as antiviral agents |
| WO2021188414A1 (en) | 2020-03-16 | 2021-09-23 | Enanta Pharmaceuticals, Inc. | Functionalized heterocyclic compounds as antiviral agents |
| TW202304914A (zh) * | 2021-04-05 | 2023-02-01 | 加拿大商愛彼特生物製藥公司 | 經取代之四環羧酸、其類似物及使用其之方法 |
| WO2024038357A1 (en) * | 2022-08-16 | 2024-02-22 | Arbutus Biopharma Corporation | Synthesis of substituted tetracyclic carboxylic acids and analogues thereof |
| CN115819200B (zh) * | 2022-11-28 | 2023-08-29 | 辽宁科技学院 | 一种苊醌的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA111756C2 (uk) * | 2011-11-03 | 2016-06-10 | Ф. Хоффманн-Ля Рош Аг | Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона |
| WO2014121416A1 (en) * | 2013-02-07 | 2014-08-14 | Merck Sharp & Dohme Corp. | Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c |
| JP6506880B2 (ja) * | 2015-07-27 | 2019-04-24 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｂ型肝炎ウィルス感染症の治療および予防のための新規な四環式４−オキソ−ピリジン−３−カルボン酸誘導体 |
| US20200270265A1 (en) * | 2016-02-19 | 2020-08-27 | Novartis Ag | Tetracyclic pyridone compounds as antivirals |
| WO2018073753A1 (en) * | 2016-10-18 | 2018-04-26 | Novartis Ag | Fused tetracyclic pyridone compounds as antivirals |
| AR111419A1 (es) * | 2017-04-27 | 2019-07-10 | Novartis Ag | Compuestos fusionados de indazol piridona como antivirales |
| CN110066278B (zh) * | 2017-06-01 | 2021-06-08 | 广东东阳光药业有限公司 | 稠合三环类化合物及其在药物中的应用 |
| TWI815887B (zh) * | 2018-05-15 | 2023-09-21 | 美商愛彼特生物製藥股份有限公司 | 經取代的2,2'-雙嘧啶基化合物、其類似物及其使用方法 |
-
2020
- 2020-01-10 TW TW109100934A patent/TW202033523A/zh unknown
- 2020-01-15 JP JP2021541219A patent/JP2022518456A/ja active Pending
- 2020-01-15 BR BR112021014079-4A patent/BR112021014079A2/pt not_active IP Right Cessation
- 2020-01-15 MX MX2021008646A patent/MX2021008646A/es unknown
- 2020-01-15 EP EP20742028.2A patent/EP3911653A4/en not_active Withdrawn
- 2020-01-15 WO PCT/US2020/013701 patent/WO2020150366A1/en not_active Ceased
- 2020-01-15 US US17/423,151 patent/US20220125771A1/en not_active Abandoned
- 2020-01-15 EA EA202191967A patent/EA202191967A1/ru unknown
- 2020-01-15 CN CN202080016321.4A patent/CN113825756A/zh active Pending
- 2020-01-15 CA CA3126102A patent/CA3126102A1/en active Pending
- 2020-01-15 AU AU2020208371A patent/AU2020208371A1/en not_active Abandoned
- 2020-01-15 SG SG11202106965RA patent/SG11202106965RA/en unknown
- 2020-01-15 PH PH1/2021/551718A patent/PH12021551718A1/en unknown
- 2020-01-15 KR KR1020217023731A patent/KR20210121044A/ko not_active Ceased
-
2021
- 2021-07-14 IL IL284845A patent/IL284845A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022518456A5 (https=) | ||
| JP2019534291A5 (https=) | ||
| JP7113009B2 (ja) | 置換ピリジノン含有三環式化合物およびそれを使用する方法 | |
| AU2008265397B9 (en) | Bromo-phenyl substituted thiazolyl dihydropyrimidines | |
| US8921381B2 (en) | Inhibitors of secretion of hepatitis B virus antigens | |
| TWI486348B (zh) | Ｃ型肝炎病毒之抑制劑 | |
| JP6667547B2 (ja) | Ｔｌｒ７作動薬およびｈｂｖカプシド集合阻害剤を用いた併用処置 | |
| JP6219414B2 (ja) | 新規なヌクレオシドホスホロアミデート化合物およびその使用 | |
| JP2022518456A (ja) | 置換多環式カルボン酸、その類似体、およびそれらの使用法 | |
| JPWO2020150366A5 (https=) | ||
| CN101328169A (zh) | 一种乙氧碳酰基-取代噻唑二氢嘧啶 | |
| IL186750A (en) | Patridines, their uses in preparing HCV replication inhibitors, their compositions and combinations | |
| TW201811371A (zh) | 利用tlr7促效劑及hbv蛋白殼組裝抑制劑之組合治療 | |
| JP2019509288A (ja) | 非環状抗ウイルス 優先出願の参照による組み込み | |
| JP2022522312A (ja) | ピロール化合物 | |
| JP2023504690A (ja) | フェニルイソキサゾリルメチレン－ナフタレン－エーテル誘導体の使用、及び医薬組成物 | |
| EP4347036A1 (en) | Fused heterocyclic derivatives | |
| US11957683B2 (en) | Bicyclic compounds | |
| EP1382343B1 (en) | Combination therapy to treat hepatitis B virus | |
| JPWO2020086533A5 (https=) | ||
| KR20210126636A (ko) | 이환식 설폰아마이드 | |
| JPWO2020243135A5 (https=) | ||
| CN113891889A (zh) | 作为衣壳组装调节剂的二氮杂卓酮衍生物 | |
| JP7717704B2 (ja) | Ｂ型肝炎ウイルスのスピロ環式阻害剤 | |
| WO2022116998A1 (en) | Fused heterocyclic derivatives as hbv inhibitors |